GO:0030126 | COPI vesicle coat | 9.60e-12 | 1.38e-07 | 9.424 | 4 | 7 | 12 |
GO:0048205 | COPI coating of Golgi vesicle | 1.39e-11 | 2.00e-07 | 9.308 | 4 | 8 | 13 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 2.45e-10 | 3.53e-06 | 8.365 | 4 | 8 | 25 |
GO:0061024 | membrane organization | 1.98e-09 | 2.86e-05 | 6.151 | 5 | 12 | 145 |
GO:0006886 | intracellular protein transport | 6.49e-07 | 9.37e-03 | 5.591 | 4 | 7 | 171 |
GO:0005829 | cytosol | 4.62e-06 | 6.66e-02 | 2.531 | 7 | 61 | 2496 |
GO:0015935 | small ribosomal subunit | 2.74e-05 | 3.95e-01 | 7.921 | 2 | 9 | 17 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 2.74e-05 | 3.95e-01 | 7.921 | 2 | 4 | 17 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 1.26e-04 | 1.00e+00 | 6.839 | 2 | 3 | 36 |
GO:0022627 | cytosolic small ribosomal subunit | 1.48e-04 | 1.00e+00 | 6.723 | 2 | 20 | 39 |
GO:0016020 | membrane | 3.67e-04 | 1.00e+00 | 2.616 | 5 | 41 | 1681 |
GO:0021691 | cerebellar Purkinje cell layer maturation | 4.85e-04 | 1.00e+00 | 11.009 | 1 | 1 | 1 |
GO:0019083 | viral transcription | 6.42e-04 | 1.00e+00 | 5.669 | 2 | 20 | 81 |
GO:0006415 | translational termination | 7.41e-04 | 1.00e+00 | 5.566 | 2 | 20 | 87 |
GO:0006414 | translational elongation | 8.46e-04 | 1.00e+00 | 5.470 | 2 | 20 | 93 |
GO:0071338 | positive regulation of hair follicle cell proliferation | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:0090135 | actin filament branching | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:0060661 | submandibular salivary gland formation | 9.70e-04 | 1.00e+00 | 10.009 | 1 | 1 | 2 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 1.06e-03 | 1.00e+00 | 5.308 | 2 | 20 | 104 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.27e-03 | 1.00e+00 | 5.176 | 2 | 20 | 114 |
GO:0019058 | viral life cycle | 1.29e-03 | 1.00e+00 | 5.163 | 2 | 23 | 115 |
GO:0051683 | establishment of Golgi localization | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 2 | 3 |
GO:0034191 | apolipoprotein A-I receptor binding | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0003161 | cardiac conduction system development | 1.46e-03 | 1.00e+00 | 9.424 | 1 | 1 | 3 |
GO:0006413 | translational initiation | 1.67e-03 | 1.00e+00 | 4.975 | 2 | 21 | 131 |
GO:0003735 | structural constituent of ribosome | 1.82e-03 | 1.00e+00 | 4.911 | 2 | 22 | 137 |
GO:0060684 | epithelial-mesenchymal cell signaling | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 4 |
GO:0051835 | positive regulation of synapse structural plasticity | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 4 |
GO:0048664 | neuron fate determination | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 1 | 4 |
GO:0072384 | organelle transport along microtubule | 1.94e-03 | 1.00e+00 | 9.009 | 1 | 2 | 4 |
GO:0005198 | structural molecule activity | 2.18e-03 | 1.00e+00 | 4.780 | 2 | 6 | 150 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 2.42e-03 | 1.00e+00 | 8.687 | 1 | 1 | 5 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.42e-03 | 1.00e+00 | 8.687 | 1 | 3 | 5 |
GO:0036336 | dendritic cell migration | 2.42e-03 | 1.00e+00 | 8.687 | 1 | 1 | 5 |
GO:0031256 | leading edge membrane | 2.42e-03 | 1.00e+00 | 8.687 | 1 | 1 | 5 |
GO:0060789 | hair follicle placode formation | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 6 |
GO:0007097 | nuclear migration | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 6 |
GO:0003334 | keratinocyte development | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 6 |
GO:0048554 | positive regulation of metalloenzyme activity | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 6 |
GO:0043497 | regulation of protein heterodimerization activity | 2.91e-03 | 1.00e+00 | 8.424 | 1 | 1 | 6 |
GO:0030157 | pancreatic juice secretion | 3.39e-03 | 1.00e+00 | 8.201 | 1 | 1 | 7 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 3.39e-03 | 1.00e+00 | 8.201 | 1 | 1 | 7 |
GO:0034101 | erythrocyte homeostasis | 3.39e-03 | 1.00e+00 | 8.201 | 1 | 1 | 7 |
GO:0051489 | regulation of filopodium assembly | 3.39e-03 | 1.00e+00 | 8.201 | 1 | 1 | 7 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 3.44e-03 | 1.00e+00 | 4.446 | 2 | 4 | 189 |
GO:0090136 | epithelial cell-cell adhesion | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 1 | 9 |
GO:0016071 | mRNA metabolic process | 4.75e-03 | 1.00e+00 | 4.208 | 2 | 25 | 223 |
GO:0031274 | positive regulation of pseudopodium assembly | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 2 | 10 |
GO:0060047 | heart contraction | 4.84e-03 | 1.00e+00 | 7.687 | 1 | 1 | 10 |
GO:0006412 | translation | 5.04e-03 | 1.00e+00 | 4.163 | 2 | 23 | 230 |
GO:0016070 | RNA metabolic process | 5.80e-03 | 1.00e+00 | 4.060 | 2 | 25 | 247 |
GO:0019082 | viral protein processing | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 2 | 12 |
GO:0042274 | ribosomal small subunit biogenesis | 5.81e-03 | 1.00e+00 | 7.424 | 1 | 6 | 12 |
GO:0032479 | regulation of type I interferon production | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 2 | 13 |
GO:0031333 | negative regulation of protein complex assembly | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 1 | 14 |
GO:0031996 | thioesterase binding | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 1 | 14 |
GO:0030131 | clathrin adaptor complex | 6.78e-03 | 1.00e+00 | 7.201 | 1 | 2 | 14 |
GO:0031369 | translation initiation factor binding | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 1 | 15 |
GO:0051233 | spindle midzone | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 2 | 15 |
GO:0030225 | macrophage differentiation | 7.26e-03 | 1.00e+00 | 7.102 | 1 | 1 | 15 |
GO:0042176 | regulation of protein catabolic process | 7.74e-03 | 1.00e+00 | 7.009 | 1 | 3 | 16 |
GO:0075733 | intracellular transport of virus | 8.22e-03 | 1.00e+00 | 6.921 | 1 | 3 | 17 |
GO:0030742 | GTP-dependent protein binding | 8.22e-03 | 1.00e+00 | 6.921 | 1 | 1 | 17 |
GO:0090316 | positive regulation of intracellular protein transport | 8.22e-03 | 1.00e+00 | 6.921 | 1 | 1 | 17 |
GO:0019068 | virion assembly | 8.22e-03 | 1.00e+00 | 6.921 | 1 | 2 | 17 |
GO:0007088 | regulation of mitosis | 8.71e-03 | 1.00e+00 | 6.839 | 1 | 1 | 18 |
GO:0046847 | filopodium assembly | 9.19e-03 | 1.00e+00 | 6.761 | 1 | 1 | 19 |
GO:0043473 | pigmentation | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 1 | 20 |
GO:0031435 | mitogen-activated protein kinase kinase kinase binding | 1.01e-02 | 1.00e+00 | 6.616 | 1 | 1 | 21 |
GO:0031424 | keratinization | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 1 | 22 |
GO:0007220 | Notch receptor processing | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 2 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.06e-02 | 1.00e+00 | 6.549 | 1 | 3 | 22 |
GO:0044822 | poly(A) RNA binding | 1.10e-02 | 1.00e+00 | 2.549 | 3 | 32 | 1056 |
GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading | 1.11e-02 | 1.00e+00 | 6.485 | 1 | 1 | 23 |
GO:0002040 | sprouting angiogenesis | 1.11e-02 | 1.00e+00 | 6.485 | 1 | 1 | 23 |
GO:0051017 | actin filament bundle assembly | 1.11e-02 | 1.00e+00 | 6.485 | 1 | 1 | 23 |
GO:0007163 | establishment or maintenance of cell polarity | 1.16e-02 | 1.00e+00 | 6.424 | 1 | 1 | 24 |
GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 2 | 25 |
GO:0005978 | glycogen biosynthetic process | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 2 | 26 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 2 | 26 |
GO:0045859 | regulation of protein kinase activity | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 1 | 26 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 2 | 26 |
GO:0051149 | positive regulation of muscle cell differentiation | 1.30e-02 | 1.00e+00 | 6.254 | 1 | 1 | 27 |
GO:0032467 | positive regulation of cytokinesis | 1.30e-02 | 1.00e+00 | 6.254 | 1 | 1 | 27 |
GO:0031069 | hair follicle morphogenesis | 1.30e-02 | 1.00e+00 | 6.254 | 1 | 1 | 27 |
GO:0072686 | mitotic spindle | 1.40e-02 | 1.00e+00 | 6.151 | 1 | 1 | 29 |
GO:0031647 | regulation of protein stability | 1.45e-02 | 1.00e+00 | 6.102 | 1 | 1 | 30 |
GO:0032480 | negative regulation of type I interferon production | 1.54e-02 | 1.00e+00 | 6.009 | 1 | 2 | 32 |
GO:0042692 | muscle cell differentiation | 1.64e-02 | 1.00e+00 | 5.921 | 1 | 1 | 34 |
GO:0034332 | adherens junction organization | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 2 | 36 |
GO:0045740 | positive regulation of DNA replication | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 1 | 36 |
GO:0007249 | I-kappaB kinase/NF-kappaB signaling | 1.97e-02 | 1.00e+00 | 5.651 | 1 | 3 | 41 |
GO:0044267 | cellular protein metabolic process | 2.03e-02 | 1.00e+00 | 3.120 | 2 | 23 | 474 |
GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 2.07e-02 | 1.00e+00 | 5.582 | 1 | 2 | 43 |
GO:0021762 | substantia nigra development | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 1 | 44 |
GO:0034613 | cellular protein localization | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 2 | 44 |
GO:0008344 | adult locomotory behavior | 2.12e-02 | 1.00e+00 | 5.549 | 1 | 1 | 44 |
GO:0043525 | positive regulation of neuron apoptotic process | 2.21e-02 | 1.00e+00 | 5.485 | 1 | 2 | 46 |
GO:0007030 | Golgi organization | 2.35e-02 | 1.00e+00 | 5.394 | 1 | 2 | 49 |
GO:0007254 | JNK cascade | 2.35e-02 | 1.00e+00 | 5.394 | 1 | 3 | 49 |
GO:0030175 | filopodium | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 2 | 50 |
GO:0030666 | endocytic vesicle membrane | 2.54e-02 | 1.00e+00 | 5.281 | 1 | 2 | 53 |
GO:0016032 | viral process | 2.54e-02 | 1.00e+00 | 2.948 | 2 | 33 | 534 |
GO:0051403 | stress-activated MAPK cascade | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 3 | 54 |
GO:0046330 | positive regulation of JNK cascade | 2.64e-02 | 1.00e+00 | 5.227 | 1 | 1 | 55 |
GO:0016197 | endosomal transport | 2.73e-02 | 1.00e+00 | 5.176 | 1 | 3 | 57 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 2.83e-02 | 1.00e+00 | 5.126 | 1 | 1 | 59 |
GO:0032481 | positive regulation of type I interferon production | 2.92e-02 | 1.00e+00 | 5.078 | 1 | 3 | 61 |
GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway | 2.92e-02 | 1.00e+00 | 5.078 | 1 | 2 | 61 |
GO:0030141 | secretory granule | 2.97e-02 | 1.00e+00 | 5.055 | 1 | 1 | 62 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 3.07e-02 | 1.00e+00 | 5.009 | 1 | 6 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.11e-02 | 1.00e+00 | 4.986 | 1 | 6 | 65 |
GO:0034146 | toll-like receptor 5 signaling pathway | 3.11e-02 | 1.00e+00 | 4.986 | 1 | 4 | 65 |
GO:0031295 | T cell costimulation | 3.11e-02 | 1.00e+00 | 4.986 | 1 | 3 | 65 |
GO:0034166 | toll-like receptor 10 signaling pathway | 3.11e-02 | 1.00e+00 | 4.986 | 1 | 4 | 65 |
GO:0045087 | innate immune response | 3.12e-02 | 1.00e+00 | 2.790 | 2 | 8 | 596 |
GO:0035264 | multicellular organism growth | 3.21e-02 | 1.00e+00 | 4.943 | 1 | 1 | 67 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.35e-02 | 1.00e+00 | 4.879 | 1 | 8 | 70 |
GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 3.40e-02 | 1.00e+00 | 4.859 | 1 | 4 | 71 |
GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 3.40e-02 | 1.00e+00 | 4.859 | 1 | 4 | 71 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 6 | 72 |
GO:0034162 | toll-like receptor 9 signaling pathway | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 4 | 72 |
GO:0034134 | toll-like receptor 2 signaling pathway | 3.49e-02 | 1.00e+00 | 4.819 | 1 | 4 | 73 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 3.54e-02 | 1.00e+00 | 4.799 | 1 | 2 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 3.54e-02 | 1.00e+00 | 4.799 | 1 | 8 | 74 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 6 | 75 |
GO:0060070 | canonical Wnt signaling pathway | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 1 | 75 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 3.63e-02 | 1.00e+00 | 4.761 | 1 | 4 | 76 |
GO:0010629 | negative regulation of gene expression | 3.68e-02 | 1.00e+00 | 4.742 | 1 | 2 | 77 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 3.73e-02 | 1.00e+00 | 4.723 | 1 | 4 | 78 |
GO:0005179 | hormone activity | 3.77e-02 | 1.00e+00 | 4.705 | 1 | 1 | 79 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 3.77e-02 | 1.00e+00 | 4.705 | 1 | 8 | 79 |
GO:0034138 | toll-like receptor 3 signaling pathway | 3.77e-02 | 1.00e+00 | 4.705 | 1 | 4 | 79 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 3.82e-02 | 1.00e+00 | 4.687 | 1 | 4 | 80 |
GO:0010467 | gene expression | 3.86e-02 | 1.00e+00 | 2.623 | 2 | 29 | 669 |
GO:0045177 | apical part of cell | 3.87e-02 | 1.00e+00 | 4.669 | 1 | 1 | 81 |
GO:0050852 | T cell receptor signaling pathway | 4.05e-02 | 1.00e+00 | 4.599 | 1 | 2 | 85 |
GO:0000187 | activation of MAPK activity | 4.29e-02 | 1.00e+00 | 4.517 | 1 | 2 | 90 |
GO:0071456 | cellular response to hypoxia | 4.38e-02 | 1.00e+00 | 4.485 | 1 | 3 | 92 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 4.38e-02 | 1.00e+00 | 4.485 | 1 | 6 | 92 |
GO:0006364 | rRNA processing | 4.47e-02 | 1.00e+00 | 4.454 | 1 | 7 | 94 |
GO:0034142 | toll-like receptor 4 signaling pathway | 4.57e-02 | 1.00e+00 | 4.424 | 1 | 4 | 96 |
GO:0030496 | midbody | 5.13e-02 | 1.00e+00 | 4.254 | 1 | 2 | 108 |
GO:0002224 | toll-like receptor signaling pathway | 5.17e-02 | 1.00e+00 | 4.241 | 1 | 4 | 109 |
GO:0005815 | microtubule organizing center | 5.17e-02 | 1.00e+00 | 4.241 | 1 | 3 | 109 |
GO:0097190 | apoptotic signaling pathway | 5.36e-02 | 1.00e+00 | 4.189 | 1 | 3 | 113 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 5.45e-02 | 1.00e+00 | 4.163 | 1 | 4 | 115 |
GO:0000209 | protein polyubiquitination | 5.50e-02 | 1.00e+00 | 4.151 | 1 | 7 | 116 |
GO:0006006 | glucose metabolic process | 5.59e-02 | 1.00e+00 | 4.126 | 1 | 3 | 118 |
GO:0007219 | Notch signaling pathway | 5.68e-02 | 1.00e+00 | 4.102 | 1 | 3 | 120 |
GO:0030036 | actin cytoskeleton organization | 5.82e-02 | 1.00e+00 | 4.066 | 1 | 2 | 123 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 5.87e-02 | 1.00e+00 | 4.055 | 1 | 3 | 124 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 6.05e-02 | 1.00e+00 | 4.009 | 1 | 3 | 128 |
GO:0000086 | G2/M transition of mitotic cell cycle | 6.42e-02 | 1.00e+00 | 3.921 | 1 | 5 | 136 |
GO:0005911 | cell-cell junction | 6.42e-02 | 1.00e+00 | 3.921 | 1 | 2 | 136 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 6.83e-02 | 1.00e+00 | 3.829 | 1 | 3 | 145 |
GO:0010628 | positive regulation of gene expression | 6.88e-02 | 1.00e+00 | 3.819 | 1 | 4 | 146 |
GO:0034220 | ion transmembrane transport | 7.01e-02 | 1.00e+00 | 3.790 | 1 | 2 | 149 |
GO:0000082 | G1/S transition of mitotic cell cycle | 7.01e-02 | 1.00e+00 | 3.790 | 1 | 9 | 149 |
GO:0042981 | regulation of apoptotic process | 7.06e-02 | 1.00e+00 | 3.780 | 1 | 7 | 150 |
GO:0010008 | endosome membrane | 7.10e-02 | 1.00e+00 | 3.770 | 1 | 5 | 151 |
GO:0008543 | fibroblast growth factor receptor signaling pathway | 7.33e-02 | 1.00e+00 | 3.723 | 1 | 3 | 156 |
GO:0043005 | neuron projection | 7.38e-02 | 1.00e+00 | 3.714 | 1 | 6 | 157 |
GO:0038095 | Fc-epsilon receptor signaling pathway | 7.88e-02 | 1.00e+00 | 3.616 | 1 | 3 | 168 |
GO:0005737 | cytoplasm | 8.13e-02 | 1.00e+00 | 1.130 | 4 | 43 | 3767 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 8.60e-02 | 1.00e+00 | 3.485 | 1 | 3 | 184 |
GO:0003924 | GTPase activity | 9.18e-02 | 1.00e+00 | 3.387 | 1 | 7 | 197 |
GO:0070062 | extracellular vesicular exosome | 9.54e-02 | 1.00e+00 | 1.365 | 3 | 40 | 2400 |
GO:0006184 | GTP catabolic process | 9.94e-02 | 1.00e+00 | 3.267 | 1 | 7 | 214 |
GO:0019221 | cytokine-mediated signaling pathway | 1.02e-01 | 1.00e+00 | 3.221 | 1 | 2 | 221 |
GO:0043025 | neuronal cell body | 1.13e-01 | 1.00e+00 | 3.072 | 1 | 4 | 245 |
GO:0005975 | carbohydrate metabolic process | 1.17e-01 | 1.00e+00 | 3.026 | 1 | 3 | 253 |
GO:0000166 | nucleotide binding | 1.19e-01 | 1.00e+00 | 2.992 | 1 | 2 | 259 |
GO:0006281 | DNA repair | 1.20e-01 | 1.00e+00 | 2.981 | 1 | 4 | 261 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 1.23e-01 | 1.00e+00 | 2.937 | 1 | 4 | 269 |
GO:0043065 | positive regulation of apoptotic process | 1.23e-01 | 1.00e+00 | 2.943 | 1 | 6 | 268 |
GO:0007264 | small GTPase mediated signal transduction | 1.28e-01 | 1.00e+00 | 2.885 | 1 | 7 | 279 |
GO:0005525 | GTP binding | 1.41e-01 | 1.00e+00 | 2.733 | 1 | 7 | 310 |
GO:0019901 | protein kinase binding | 1.44e-01 | 1.00e+00 | 2.700 | 1 | 6 | 317 |
GO:0043231 | intracellular membrane-bounded organelle | 1.45e-01 | 1.00e+00 | 2.696 | 1 | 5 | 318 |
GO:0007411 | axon guidance | 1.45e-01 | 1.00e+00 | 2.691 | 1 | 3 | 319 |
GO:0000139 | Golgi membrane | 1.63e-01 | 1.00e+00 | 2.513 | 1 | 6 | 361 |
GO:0005925 | focal adhesion | 1.65e-01 | 1.00e+00 | 2.493 | 1 | 19 | 366 |
GO:0000278 | mitotic cell cycle | 1.75e-01 | 1.00e+00 | 2.398 | 1 | 11 | 391 |
GO:0043066 | negative regulation of apoptotic process | 1.89e-01 | 1.00e+00 | 2.281 | 1 | 13 | 424 |
GO:0055085 | transmembrane transport | 1.93e-01 | 1.00e+00 | 2.244 | 1 | 3 | 435 |
GO:0007596 | blood coagulation | 2.01e-01 | 1.00e+00 | 2.179 | 1 | 3 | 455 |
GO:0042802 | identical protein binding | 2.13e-01 | 1.00e+00 | 2.090 | 1 | 3 | 484 |
GO:0006915 | apoptotic process | 2.40e-01 | 1.00e+00 | 1.892 | 1 | 9 | 555 |
GO:0005783 | endoplasmic reticulum | 2.41e-01 | 1.00e+00 | 1.890 | 1 | 3 | 556 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 2.46e-01 | 1.00e+00 | 1.854 | 1 | 7 | 570 |
GO:0005794 | Golgi apparatus | 2.61e-01 | 1.00e+00 | 1.756 | 1 | 9 | 610 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 3.26e-01 | 1.00e+00 | 1.385 | 1 | 6 | 789 |
GO:0005886 | plasma membrane | 3.65e-01 | 1.00e+00 | 0.674 | 2 | 20 | 2582 |
GO:0005615 | extracellular space | 3.82e-01 | 1.00e+00 | 1.106 | 1 | 2 | 957 |
GO:0005654 | nucleoplasm | 4.21e-01 | 1.00e+00 | 0.929 | 1 | 15 | 1082 |
GO:0044281 | small molecule metabolic process | 4.59e-01 | 1.00e+00 | 0.767 | 1 | 15 | 1211 |
GO:0046872 | metal ion binding | 4.86e-01 | 1.00e+00 | 0.657 | 1 | 10 | 1307 |
GO:0006351 | transcription, DNA-templated | 5.23e-01 | 1.00e+00 | 0.511 | 1 | 6 | 1446 |
GO:0005730 | nucleolus | 5.71e-01 | 1.00e+00 | 0.328 | 1 | 24 | 1641 |
GO:0005634 | nucleus | 9.30e-01 | 1.00e+00 | -1.146 | 1 | 43 | 4559 |
GO:0005515 | protein binding | 9.77e-01 | 1.00e+00 | -1.548 | 1 | 62 | 6024 |